STOCK TITAN

enGene Therapeutics: Perceptive reports 8.9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

enGene Therapeutics Inc. (ENGN) has three reporting persons—Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd.—each reporting shared beneficial ownership of 6,217,464 Common Shares, or 8.9%. The amount assumes exercise of 2,735,295 pre-funded warrants and is based on 67,016,316 Common Shares outstanding as of September 2, 2026.

The Master Fund directly holds 3,482,169 Common Shares and 2,735,295 pre-funded warrants, exercisable at $0.0001 per share subject to a 9.99% beneficial-ownership limit. The statement says the limit permits exercise of all the warrants as of September 30, 2026; Perceptive Advisors and Joseph Edelman do not directly hold Common Shares or pre-funded warrants.

Shared beneficial ownership 6,217,464 Common Shares Reported by each of the three reporting persons; amount assumes exercise of pre-funded warrants
Percentage of class 8.9% Reported by each reporting person
Common Shares outstanding 67,016,316 Common Shares As of September 2, 2026; basis for reported ownership percentages
Common Shares directly held 3,482,169 Common Shares Held directly by Perceptive Life Sciences Master Fund, Ltd.
Pre-funded warrants 2,735,295 warrants Held directly by Perceptive Life Sciences Master Fund, Ltd.; immediately exercisable for Common Shares, subject to the Beneficial Ownership Limitation
Warrant exercise price $0.0001 per share Exercise price for the pre-funded warrants
Beneficial Ownership Limitation 9.99% Limit on beneficial ownership following warrant exercise
pre-funded warrants financial
"2,735,295 Pre-Funded Warrants held by the Reporting Persons"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Beneficial Ownership Limitation regulatory
"subject to the Beneficial Ownership Limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
shared voting power technical
"Shared power to vote or to direct the vote"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power technical
"Shared power to dispose or to direct the disposition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much ENGN beneficial ownership did the reporting persons report?

Each of Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. reported shared beneficial ownership of 6,217,464 Common Shares, or 8.9%. The same shared amount is reported for each; it is not three separate holdings to add together.

What are the terms of ENGN's pre-funded warrants held by the Master Fund?

The Master Fund directly holds 2,735,295 pre-funded warrants, immediately exercisable for Common Shares at $0.0001 per share, subject to a 9.99% Beneficial Ownership Limitation. As of September 30, 2026, the limitation permitted exercise of all the warrants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





29286X101

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Perceptive Advisors LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026
Joseph Edelman
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:11/16/2026
Perceptive Life Sciences Master Fund, Ltd.
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026

Keep reading